title: The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.
authors.affiliation: Sorbonne Universités, UPMC, Univ Paris 06, Paris INSERM U1135, CIMI-Paris AP-HP, Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris magali.legarff@psl.aphp.fr.
authors.forename: Magali
authors.initials: M
authors.lastname: Le Garff-Tavernier
authors.affiliation: Sorbonne Universités, UPMC, Univ Paris 06, Paris INSERM U1135, CIMI-Paris Laboratoire Français de Fractionnement et des Biotechnologies (LFB), Les Ulis.
authors.forename: Linda
authors.initials: L
authors.lastname: Herbi
authors.affiliation: Laboratoire Français de Fractionnement et des Biotechnologies (LFB), Les Ulis.
authors.forename: Christophe
authors.initials: C
authors.lastname: de Romeuf
authors.affiliation: AP-HP, Hôpital Pitié-Salpêtrière, Service d'Hématologie Clinique, Paris.
authors.forename: Nabih
authors.initials: N
authors.lastname: Azar
authors.affiliation: Sorbonne Universités, UPMC, Univ Paris 06, Paris AP-HP, Hôpital Pitié-Salpêtrière, Service d'Hématologie Clinique, Paris.
authors.forename: Damien
authors.initials: D
authors.lastname: Roos-Weil
authors.affiliation: AP-HP, Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris.
authors.forename: Patrick
authors.initials: P
authors.lastname: Bonnemye
authors.affiliation: Laboratoire Français de Fractionnement et des Biotechnologies (LFB), Les Ulis.
authors.forename: Rémi
authors.initials: R
authors.lastname: Urbain
authors.affiliation: Sorbonne Universités, UPMC, Univ Paris 06, Paris AP-HP, Hôpital Pitié-Salpêtrière, Service d'Hématologie Clinique, Paris.
authors.forename: Véronique
authors.initials: V
authors.lastname: Leblond
authors.affiliation: Sorbonne Universités, UPMC, Univ Paris 06, Paris AP-HP, Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris INSERM U1138, Programmed cell death and physiopathology of tumor cells, team 19, Centre de Recherche des Cordeliers, Paris.
authors.forename: Hélène
authors.initials: H
authors.lastname: Merle-Beral
authors.affiliation: Sorbonne Universités, UPMC, Univ Paris 06, Paris INSERM U1135, CIMI-Paris CNRS, ERL8255, CIMI-Paris, Paris, France.
authors.forename: Vincent
authors.initials: V
authors.lastname: Vieillard
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology* / Q000378:metabolism; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D000069283:Rituximab; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000069283:Rituximab
keywords: ADCC; Waldenström macroglobulinemia; natural killer; ublituximab